These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Metastatic Crohn's disease in childhood: A case report. Saito K; Iwata Y; Nakajima Y; Numata S; Sugiura K J Dermatol; 2018 Jul; 45(7):e199-e200. PubMed ID: 29341218 [No Abstract] [Full Text] [Related]
45. Systemic Absorption of Topical Tacrolimus in Metastatic Crohn Disease With Skin Ulcers. García-Delgado R; Escario-Travesedo E; Sánchez-Romero A Actas Dermosifiliogr; 2016 Dec; 107(10):866-867. PubMed ID: 27372545 [No Abstract] [Full Text] [Related]
46. Cutaneous Crohn's disease treated with infliximab and 4 years of follow up. Yoong C; Schofield C; Rodins K; Faulkner C Australas J Dermatol; 2014 Aug; 55(3):e40-3. PubMed ID: 23772972 [TBL] [Abstract][Full Text] [Related]
47. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506). Fellermann K; Ludwig D; Stahl M; David-Walek T; Stange EF Am J Gastroenterol; 1998 Oct; 93(10):1860-6. PubMed ID: 9772045 [TBL] [Abstract][Full Text] [Related]
48. Topical tacrolimus may be effective in the treatment of oral and perineal Crohn's disease. Casson DH; Eltumi M; Tomlin S; Walker-Smith JA; Murch SH Gut; 2000 Sep; 47(3):436-40. PubMed ID: 10940284 [TBL] [Abstract][Full Text] [Related]
49. Toxic tacrolimus levels after application of topical tacrolimus and use of occlusive dressings in two bone marrow transplant recipients with cutaneous graft-versus-host disease. Olson KA; West K; McCarthy PL Pharmacotherapy; 2014 Jun; 34(6):e60-4. PubMed ID: 24700567 [TBL] [Abstract][Full Text] [Related]
50. Successful response to topical tacrolimus for a granuloma faciale in an elderly patient. Pérez-Robayna N; Rodríguez-García C; González-Hernández S; Sánchez R; Guimerá F; Sáez M Dermatology; 2009; 219(4):359-60. PubMed ID: 19797891 [No Abstract] [Full Text] [Related]
51. The expanding role of topical tacrolimus in dermatology. Evans AV Clin Exp Dermatol; 2005 Mar; 30(2):111-5. PubMed ID: 15725232 [No Abstract] [Full Text] [Related]
52. Granuloma faciale: a case report on long-term treatment with topical tacrolimus and dermoscopic aspects. Caldarola G; Zalaudek I; Argenziano G; Bisceglia M; Pellicano R Dermatol Ther; 2011; 24(5):508-11. PubMed ID: 22353159 [TBL] [Abstract][Full Text] [Related]
53. Lymphocytoma cutis treated with topical tacrolimus. El-Dars LD; Statham BN; Blackford S; Williams N Clin Exp Dermatol; 2005 May; 30(3):305-7. PubMed ID: 15807704 [No Abstract] [Full Text] [Related]
54. Remission maintained by monotherapy after biological + immunosuppressive combination for Crohn's disease in clinical practice. Ampuero J; Rojas-Feria M; Castro-Fernández M; Millán-Lorenzo M; Guerrero-Jiménez P; Romero-Gómez M J Gastroenterol Hepatol; 2016 Jan; 31(1):112-8. PubMed ID: 26173493 [TBL] [Abstract][Full Text] [Related]
55. Metastatic Crohn's disease of the penis in a pediatric patient. Pohl JF; Comstock JM; Oottamasathien S Inflamm Bowel Dis; 2011 Apr; 17(4):1056. PubMed ID: 20645314 [No Abstract] [Full Text] [Related]
56. Cutaneous Crohn's disease in the pediatric population. Vaid RM; Cohen BA Pediatr Dermatol; 2010; 27(3):279-81. PubMed ID: 20609145 [TBL] [Abstract][Full Text] [Related]
57. [Tacrolimus in perianal manifestations of Crohn's disease]. Nanaeva BA; Vardanian AV Eksp Klin Gastroenterol; 2013; (3):53-7. PubMed ID: 24294772 [No Abstract] [Full Text] [Related]
58. Innovative use of topical calcineurin inhibitors. Lin AN Dermatol Clin; 2010 Jul; 28(3):535-45. PubMed ID: 20510763 [TBL] [Abstract][Full Text] [Related]